Age-dependent spatial memory deficits in transgenic mice expressing the human mid-sized neurofilament gene: I

Molecular Brain Research

Volumn 42, Issue 1, 1996, Pages 62-70

  Haroutunian, Vahram ^a   Zhou, Yili ^a   Elder, Gregory ^b   Li, Chi ^b   Lazzarini, Robert A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Animal model; Memory; Morris water maze; Mouse; Neurofilament; Transgenic mouse

Indexed keywords

NEUROFILAMENT PROTEIN;

AGING; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOLOGY; LEARNING; MALE; MAZE TEST; MOUSE; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; TRANSGENIC MOUSE; WORKING MEMORY;

ANIMALIA; MUS MUSCULUS;

EID: 0030297779     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00114-3     Document Type: Article

References (38)

1. [1] Arnsten, A.F. and Goldman-Rakic, P.S., Analysis of alpha-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeys, Neurobiol. Aging, 11 (1990) 583-590.
2. [2] Cammarata, S., Mancardi, G. and Tabaton, M., Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer's disease, Neurosci. Lett., 115 (1990) 351-355.
3. [3] Decker, M.W. and McGaugh, J.L., The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory, Synapse, 7 (1991) 151-168.
4. [4] DeKosky, S.T. and Scheff, S.W., Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity, Ann. Neurol., 27 (1990) 457-464.
5. [5] Eichenbaum, H., Stewart, C. and Morris, R.G., Hippocampal representation in place learning, J. Neurosci., 10 (1990) 3531-3542.
6. [6] Galloway, P., Grundke-Iqbal, I., Iqbal, K. and Perry, G., Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles, J. Neuropathol. Exp. Neurol., 47 (1988) 654-663.
7. [7] Galloway, P., Mulvihill, P. and Perry, G., Filaments of Lewy bodies contain insoluble cytoskeletal elements, Am. J. Pathol., 140 (1992) 809-822.
8. [8] Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagoplan, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masilah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganinl, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B. and Zhao, J., Alzheimer-type neuropathology in transgenic mice overexpressing V717F B-amyloid precursor protein, Nature, 373 (1995) 523-527.
9. [9] Goldman, J. and Yen, S., Lewy bodies of Parkinson's disease contain neurofilament antigens, Science, 221 (1983) 1082-1084.
10. [10] Goldman, P., Functional development of the prefrontal cortex in early life and the problem of neuronal plasticity, Exp. Neurol., 32 (1971) 366-387.
11. [11] Goldman-Rakic, P.S. and Selemon, L.D., New frontiers in basal ganglia research. Introduction, Trends Neurosci., 13 (1990) 241-244.
12. [12] Gower, A.J., Lesioning of the nucleus basalis in the rat as a model of Alzheimer's disease, Trends Pharmacol. Sci., Nov. (1986) 432-434.
13. [13] Haroutunian, V., Kanof, P.D. and Davis, K.L., Interactions of forebrain cholinergic and somatostatinergic systems in the rat, Brain Res., 496 (1989) 98-104.
14. [14] Haroutunian, V., Kanof, P.D., Tsuboyama, G.K., Campbell, G.A. and Davis, K.L., Animal models of Alzheimer's disease: behavior, pharmacology, transplants, Can. J. Neurol. Sci., 13 (1986) 385-393.
15. [15] Haroutunian, V., Mantin, R. and Kanof, P.D., Frontal cortex as the site of action of physostigmine in nbM-lesioned rats, Physiol. Behav., 47 (1990) 203-206.
16. [16] Higgins, L., Holtzman, D., Rabin, J., Mobley, W. and Cordell, B., Transgenic mouse brain histopathology resembles early Alzheimer's disease, Ann. Neurol., 35 (1994) 598-607.
17. [17] Kammesheidt, A., Boyce, F.M., Spanoyannis, A.F., Cummings, B.J., Ortegon, M., Cotman, C., Vaught, J.L. and Neve, R.L., Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain, Proc. Natl. Acad. Sci. USA, 89 (1992) 10857-10861.
18. [18] Kazee, A., Eskin, T., Lapham, L., Gabriel, K., McDaniel, K. and Hamill, R., Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria, Alzheimer Dis. Assoc. Disorders, 7 (1993) 152-164.
19. [19] Lee, V.M., Carden, M.J., Schlaepfer, W.W. and Trojanowski, J.Q., Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunit (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats, J. Neurosci., 7 (1987) 3474-3488.
20. [20] Lee, V.M., Otvos, L., Carden, M.J., Hollosi, M., Dietzschold, B. and Lazzarini, R.A. Identification of the major multiphosphorylation site in mammalian neurofilaments, Proc. Natl. Acad. Sci. USA, 85 (1988) 1998-2002.
21. [21] Lee, V.M.Y., Elder, G.A., Chen, L.C., Liang, Z., Snyder, S.E., Friedrich, V.L. and Lazzarini, R.A., Expression of human mid-sized neurofilament subunit in transgenic mice, Mol. Brain Res., 15 (1992) 76-84.
22. [22] Manetto, V., Sternberger, N., Perry, G., Sternberger, L. and Gambetti, P., Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis, J. Neuropathol. Exp. Neurol., 47 (1988) 642-653.
23. [23] Miller, C., Brion, J., Calvert, R., Chin, T., Eagles, P., Downes, M., Filament-Durand, J., Haugh, M., Kahn, J., Probst, A., Ulrich, J. and Anderton, B., Alzheimer's paired helical filaments share epitopes with neurofilament side arms, EMBO J., 5 (1986) 269-276.
24. [24] Morris, R.G., Toward a representational hypothesis of the role of hippocampal synaptic plasticity in spatial and other forms of learning, Cold Spring Harb. Symp. Quant. Biol., 55 (1990) 161-173.
25. [25] Olton, D.S., Dementia: animal models of the cognitive impairments following damage to the basal forebrain cholinergic system, Brain Res. Bull., 25 (1990) 499-502.
26. [26] Perry, G., Stewart, D., Friedman, R., Manetto, V., Autilio-Gambetti, L. and Gambetti, P., Filaments of Pick's bodies contain altered cytoskeletal elements, Am. J. Pathol., 127 (1987) 559-568.
27. [27] Pleasure, S.J., Lee, V.M. and Nelson, D.L., Site-specific phosphorylation of the middle molecular weight human neurofilament protein in transfected non-neuronal cells, J. Neurosci., 10 (1990) 2428-2437.
28. [28] Quon, D., Wang, Y., Catalano, R., Scardina, J.M., Murakami, K. and Cordell, B., Formation of beta-amyloid protein deposits in brains of transgenic mice, Nature, 352 (1991) 239-241.
29. [29] Santucci, A.C., Kanof, P.D. and Haroutunian, V., Transient enhancement of cholinergic neurochemical markers induced by NGF in aged F344 rats, Dementia, 6 (1996) 179-184.
30. [30] Schmidt, M., Lee, V. and Trojanowski, J., Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles, Am. J. Pathol., 136 (1990) 1069-1075.
31. [31] Schmidt, M., Murray, J., Lee, V., Hill, W., Wertkin, A. and Trojanowski, J., Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies, Am. J. Pathol., 139 (1991) 53-65.
32. [32] Sima, A., Clark, A., Sternberger, N. and Sternberger, L., Lewy body dementia without Alzheimer changes, Can. J. Neurol. Sci., 13 (1986) 490-497.
33. [33] Smith, G., Animal models of Alzheimer's disease: experimental cholinergic denervation, Brain Res., 472 (1988) 103-118.
34. [34] Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A. and Katzman, R., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol., 30 (1991) 572-580.
35. [35] Thai, L.J., Mandel, R.J., Terry, R.D., Buzsaki, G. and Gage, F.H., Nucleus basalis lesions fail to induce senile plaques in the rat, Exp. Neurol., 108 (1990) 88-90.
36. [36] Vickers, J.C., Morrison, J.M., Friedrich, V.L., Elder, G.A., Perl, D.P., Katz, R.N. and Lazzarini, R.A., Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit, J. Neurosci., 14 (1994) 5603-5612.
37. [37] Yamaguchi, F., Richards, S.J., Beyreuther, K., Salbaum, M., Carlson, G.A. and Dunnett, S.B., Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory, NeuroReport, 2 (1991) 781-784.
38. [38] Zhang, H., Sternberger, N., Rubinstein, L., Herman, M., Binder, L. and Sternberger, L., Abnormal processing of multiple proteins in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 86 (1989) 8045-8049.